{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:15:35Z","timestamp":1768976135533,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12951-017-0272-7","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T14:44:12Z","timestamp":1494254652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury"],"prefix":"10.1186","volume":"15","author":[{"given":"Wen","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"272_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1086\/665457","volume":"87","author":"RB Borgens","year":"2012","unstructured":"Borgens RB, Liu-Snyder P. Understanding secondary injury. Quar Rev Biol. 2012;87:89\u2013127.","journal-title":"Quar Rev Biol"},{"key":"272_CR2","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00018-010-0277-y","volume":"67","author":"Q Kong","year":"2010","unstructured":"Kong Q, Lin CL. Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci. 2010;67:1817\u201329.","journal-title":"Cell Mol Life Sci"},{"key":"272_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s13311-011-0026-4","volume":"8","author":"ED Hall","year":"2011","unstructured":"Hall ED. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics. 2011;8:152\u201367.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"272_CR4","first-page":"941","volume":"8","author":"X Kong","year":"2016","unstructured":"Kong X, Gao J. Macrophage polarization: a key event in the secondary phase of acute spinal cord injury. J Cell Mol Med. 2016;8(2):941\u201354.","journal-title":"J Cell Mol Med."},{"key":"272_CR5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1096\/fasebj.29.1_supplement.lb210","volume":"29","author":"S David","year":"2015","unstructured":"David S. Mechanisms underlying macrophage polarization in spinal cord injury\u2014detrimental and beneficial influences on recovery. FASEB J. 2015;29:210\u20134.","journal-title":"FASEB J."},{"key":"272_CR6","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","volume":"29","author":"KA Kigerl","year":"2009","unstructured":"Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435\u201344.","journal-title":"J Neurosci"},{"key":"272_CR7","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1046\/j.1471-4159.2000.0752144.x","volume":"75","author":"D Liu","year":"2000","unstructured":"Liu D, Ling X, Wen J, Liu J. The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J Neurochem. 2000;75:2144\u201354.","journal-title":"J Neurochem"},{"key":"272_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1089\/neu.2005.22.1123","volume":"22","author":"D Liu","year":"2005","unstructured":"Liu D, Bao F, Prough DS, Dewitt DS. Peroxynitrite generated at the level produced by spinal cord injury induces peroxidation of membrane phospholipids in normal rat cord: reduction by a metalloporphyrin. J Neurotrauma. 2005;22:1123\u201333.","journal-title":"J Neurotrauma"},{"key":"272_CR9","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/neu.2004.21.1255","volume":"21","author":"GS Scott","year":"2004","unstructured":"Scott GS, Szab\u00f3 C, Hooper DC. Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitro. J Neurotrauma. 2004;21:1255\u201363.","journal-title":"J Neurotrauma"},{"key":"272_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1471-4159.2006.04312.x","volume":"100","author":"Y Xiong","year":"2007","unstructured":"Xiong Y, Rabchevsky AG, Hall ED. Role of peroxynitrite in secondary oxidative damage after spinal cord injury. J Neurochem. 2007;100:639\u201349.","journal-title":"J Neurochem"},{"key":"272_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.sc.3101672","volume":"43","author":"J Isaksson","year":"2005","unstructured":"Isaksson J, Farooque M, Olsson Y. Improved functional outcome after spinal cord injury in iNOS-deficient mice. Spinal Cord. 2005;43:167\u201370.","journal-title":"Spinal Cord"},{"key":"272_CR12","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1089\/neu.2012.2371","volume":"29","author":"DM Maggio","year":"2012","unstructured":"Maggio DM, Chatzipanteli K, Masters N, Patel SP, Dietrich WD, Pearse DD. Acute molecular perturbation of inducible nitric oxide synthase with an antisense approach enhances neuronal preservation and functional recovery after contusive spinal cord injury. J Neurotrauma. 2012;29:2244\u20139.","journal-title":"J Neurotrauma"},{"key":"272_CR13","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.1016\/j.biomaterials.2013.04.060","volume":"34","author":"P Resnier","year":"2013","unstructured":"Resnier P, Montier T, Mathieu V, Benoit JP, Passirani C. A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials. 2013;34:6429\u201343.","journal-title":"Biomaterials"},{"key":"272_CR14","doi-asserted-by":"publisher","unstructured":"Koutsilieri E, Rethwilm A, Scheller C. The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders. In: Gerlach M, Deckert J, Double K, Koutsilieri E, editors. Neuropsychiatric disorders an integrative approach. Journal of neural transmission. Supplementa, vol. 72. Vienna: Springer; 2007.","DOI":"10.1007\/978-3-211-73574-9_7"},{"key":"272_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/ph6030287","volume":"6","author":"KM Pauley","year":"2013","unstructured":"Pauley KM, Cha S. RNAi therapeutics in autoimmune disease. Pharmaceuticals. 2013;6:287\u201394.","journal-title":"Pharmaceuticals"},{"key":"272_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/ana.21935","volume":"67","author":"Y Yang","year":"2010","unstructured":"Yang Y, Liu Y, Wei P, Peng H, Winger R, Hussain RZ, Ben LH, Cravens PD, Gocke AR, Puttaparthi K, et al. Silencing Nogo-A promotes functional recovery in demyelinating disease. Ann Neurol. 2010;67:498\u2013507.","journal-title":"Ann Neurol"},{"key":"272_CR17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/jcbfm.2009.268","volume":"30","author":"E Kilic","year":"2010","unstructured":"Kilic E, ElAli A, Kilic U, Guo Z, Ugur M, Uslu U, Bassetti CL, Schwab ME, Hermann DM. Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab. 2010;30:969\u201384.","journal-title":"J Cereb Blood Flow Metab"},{"key":"272_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1471-4159.2010.06579.x","volume":"113","author":"C-G Yu","year":"2010","unstructured":"Yu C-G, Yezierski RP, Joshi A, Raza K, Li Y, Geddes JW. Involvement of ERK2 in traumatic spinal cord injury. J Neurochem. 2010;113:131\u201342.","journal-title":"J Neurochem"},{"key":"272_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ymthe.2006.04.010","volume":"14","author":"KA Howard","year":"2006","unstructured":"Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO, Hovgaard MB, Schmitz A, Nyengaard JR, Besenbacher F, Kjems J. RNA interference in vitro and in vivo using a novel chitosan\/siRNA nanoparticle system. Mol Ther. 2006;14:476\u201384.","journal-title":"Mol Ther"},{"key":"272_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","volume":"81","author":"A Bernkop-Schnurch","year":"2012","unstructured":"Bernkop-Schnurch A, Dunnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81:463\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"272_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1021\/ar3000162","volume":"45","author":"J Nguyen","year":"2012","unstructured":"Nguyen J, Szoka FC. Nucleic acid delivery: the missing pieces of the puzzle? Acc Chem Res. 2012;45:1153\u201362.","journal-title":"Acc Chem Res"},{"key":"272_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2013.08.005","volume":"172","author":"H Ragelle","year":"2013","unstructured":"Ragelle H, Vandermeulen G, Preat V. Chitosan-based siRNA delivery systems. J Control Release. 2013;172:207\u201318.","journal-title":"J Control Release"},{"key":"272_CR23","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1242\/jeb.035162","volume":"213","author":"Y Cho","year":"2010","unstructured":"Cho Y, Shi R, Borgens RB. Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. J Exp Biol. 2010;213:1513\u201320.","journal-title":"J Exp Biol"},{"key":"272_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrn3053","volume":"12","author":"S David","year":"2011","unstructured":"David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci. 2011;12:388\u201399.","journal-title":"Nat Rev Neurosci"},{"key":"272_CR25","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1523\/JNEUROSCI.2592-10.2011","volume":"31","author":"H-S Kuo","year":"2011","unstructured":"Kuo H-S, Tsai M-J, Huang M-C, Chiu C-W, Tsai C-Y, Lee M-J, Huang W-C, Lin Y-L, Kuo W-C, Cheng H. Acid fibroblast growth factor and peripheral nerve grafts regulate Th2 cytokine expression, macrophage activation, polyamine synthesis, and neurotrophin expression in transected rat spinal cords. J Neurosci. 2011;31:4137\u201347.","journal-title":"J Neurosci"},{"key":"272_CR26","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1523\/JNEUROSCI.4912-13.2014","volume":"34","author":"AD Greenhalgh","year":"2014","unstructured":"Greenhalgh AD, David S. Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death. J Neurosci. 2014;34:6316\u201322.","journal-title":"J Neurosci"},{"key":"272_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0169-328X(00)00253-9","volume":"85","author":"K Satake","year":"2000","unstructured":"Satake K, Matsuyama Y, Kamiya M, Kawakami H, Iwata H, Adachi K, Kiuchi K. Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Brain Res Mol Brain Res. 2000;85:114\u201322.","journal-title":"Brain Res Mol Brain Res"},{"key":"272_CR28","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.addr.2009.04.018","volume":"61","author":"YK Oh","year":"2009","unstructured":"Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61:850\u201362.","journal-title":"Adv Drug Deliv Rev"},{"key":"272_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"D Bumcrot","year":"2006","unstructured":"Bumcrot D, Manoharan M, Koteliansky V, Sah DW. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol. 2006;2:711\u20139.","journal-title":"Nat Chem Biol"},{"key":"272_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-bioeng-071813-105119","volume":"16","author":"JM Williford","year":"2014","unstructured":"Williford JM, Wu J, Ren Y, Archang MM, Leong KW, Mao HQ. Recent advances in nanoparticle-mediated siRNA delivery. Annu Rev Biomed Eng. 2014;16:347\u201370.","journal-title":"Annu Rev Biomed Eng"},{"key":"272_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/nat.2011.0293","volume":"21","author":"K Singha","year":"2011","unstructured":"Singha K, Namgung R, Kim WJ. Polymers in small-interfering RNA delivery. Nucleic Acid Ther. 2011;21:133\u201347.","journal-title":"Nucleic Acid Ther"},{"key":"272_CR32","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.foodchem.2015.06.076","volume":"190","author":"P Zou","year":"2016","unstructured":"Zou P, Yang X, Wang J, Li Y, Yu H, Zhang Y, Liu G. Advances in characterisation and biological activities of chitosan and chitosan oligosaccharides. Food Chem. 2016;190:1174\u201381.","journal-title":"Food Chem"},{"key":"272_CR33","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.biomaterials.2006.11.004","volume":"28","author":"X Liu","year":"2007","unstructured":"Liu X, Howard KA, Dong M, Andersen MO, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J. The influence of polymeric properties on chitosan\/siRNA nanoparticle formulation and gene silencing. Biomaterials. 2007;28:1280\u20138.","journal-title":"Biomaterials"},{"key":"272_CR34","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/sj.gt.3302312","volume":"11","author":"M Koping-Hoggard","year":"2004","unstructured":"Koping-Hoggard M, Varum KM, Issa M, Danielsen S, Christensen BE, Stokke BT, Artursson P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 2004;11:1441\u201352.","journal-title":"Gene Ther"},{"key":"272_CR35","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","volume":"31","author":"C He","year":"2010","unstructured":"He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31:3657\u201366.","journal-title":"Biomaterials"},{"key":"272_CR36","doi-asserted-by":"publisher","first-page":"17253","DOI":"10.1073\/pnas.1308887110","volume":"110","author":"FY McWhorter","year":"2013","unstructured":"McWhorter FY, Wang T, Nguyen P, Chung T, Liu WF. Modulation of macrophage phenotype by cell shape. Proc Natl Acad Sci. 2013;110:17253\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"272_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1165\/rcmb.2008-0046OC","volume":"39","author":"RM Gilberti","year":"2008","unstructured":"Gilberti RM, Joshi GN, Knecht DA. The phagocytosis of crystalline silica particles by macrophages. Am J Respir Cell Mol Biol. 2008;39:619\u201327.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"272_CR38","doi-asserted-by":"publisher","first-page":"26269","DOI":"10.1038\/srep26269","volume":"6","author":"Y Qie","year":"2016","unstructured":"Qie Y, Yuan H, von Roemeling CA, Chen Y, Liu X, Shih KD, Knight JA, Tun HW, Wharen RE, Jiang W, Kim BY. Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes. Sci Rep. 2016;6:26269.","journal-title":"Sci Rep"},{"key":"272_CR39","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.4049\/jimmunol.159.5.2462","volume":"159","author":"Y Shibata","year":"1997","unstructured":"Shibata Y, Metzger WJ, Myrvik QN. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J Immunol. 1997;159:2462\u20137.","journal-title":"J Immunol"},{"key":"272_CR40","series-title":"Lockwood DJ (Series Editor): Nanostructure science and technology","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4614-2305-8_4","volume-title":"Multifunctional nanoparticles for drug delivery applications: imaging, targeting, and delivery","author":"S Jain","year":"2012","unstructured":"Jain S, Amiji MM. Macrophage-targeted nanoparticle delivery systems. In: Svenson S, Prud\u2019homme RK, editors. Multifunctional nanoparticles for drug delivery applications: imaging, targeting, and delivery., Lockwood DJ (Series Editor): Nanostructure science and technologyNew York: Springer; 2012. p. 47\u201384."},{"key":"272_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.22203\/eCM.v024a10","volume":"24","author":"MI Oliveira","year":"2012","unstructured":"Oliveira MI, Santos SG, Oliveira MJ, Torres AL, Barbosa MA. Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation. Eur Cell Mater. 2012;24:136\u201352 (Discussion 152\u201333).","journal-title":"Eur Cell Mater"},{"key":"272_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/bbrc.2000.2602","volume":"271","author":"SM Hwang","year":"2000","unstructured":"Hwang SM, Chen CY, Chen SS, Chen JC. Chitinous materials inhibit nitric oxide production by activated RAW 264.7 macrophages. Biochem Biophys Res Commun. 2000;271:229\u201333.","journal-title":"Biochem Biophys Res Commun"},{"key":"272_CR43","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/czoolo\/57.3.340","volume":"57","author":"Y Cai","year":"2011","unstructured":"Cai Y, Fan R, Hua T, Liu H, Li J. Nimodipine alleviates apoptosis-mediated impairments through the mitochondrial pathway after spinal cord injury. Curr Zool. 2011;57:340\u20139.","journal-title":"Curr Zool"},{"key":"272_CR44","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","volume":"74","author":"ZN Oltvai","year":"1993","unstructured":"Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609\u201319.","journal-title":"Cell"},{"key":"272_CR45","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm0697-614","volume":"3","author":"G Kroemer","year":"1997","unstructured":"Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 1997;3:614\u201320.","journal-title":"Nat Med"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-017-0272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:15:19Z","timestamp":1719188119000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-017-0272-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["272"],"URL":"https:\/\/doi.org\/10.1186\/s12951-017-0272-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"article-number":"38"}}